Entecavir and Coenzyme q10 drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Entecavir (entecavir) and Coenzyme q10 (coenzyme q - 10). Common drug interactions include insomnia among females and alanine aminotransferase increased among males.

The phase IV clinical study analyzes what interactions people have when they take Entecavir and Coenzyme q10. It is created by eHealthMe based on reports of 16 people who take the same drugs from the FDA, and is updated regularly.

What is Entecavir?

Entecavir has active ingredients of entecavir. It is often used in hepatitis b. eHealthMe is studying from 7,354 Entecavir users. Check the latest studies of Entecavir.

What is Coenzyme q10?

Coenzyme q10 has active ingredients of coenzyme q - 10. It is often used in high blood cholesterol. eHealthMe is studying from 23,438 Coenzyme q10 users. Check the latest studies of Coenzyme q10.

On Jul, 03, 2026

16 people who take Entecavir and Coenzyme q10 together, and have interactions are studied.

Entecavir and Coenzyme q10 drug interactions.

What are the common drug interactions of Entecavir and Coenzyme Q10, by gender? *:

female:

Insomnia (sleeplessness)
Oxygen saturation decreased
Pneumonia
Pneumonitis (inflammation of the walls of the alveoli in the lungs)
Pulmonary oedema (fluid accumulation in the lungs)
Stress
White blood cell count decreased
Presyncope
Bone marrow failure
Crying

male:

Alanine aminotransferase increased
Aspartate aminotransferase increased
Pain in extremity
Plantar erythema (soles of the feet)
Toxic epidermal necrolysis (a rare, life-threatening skin condition that is usually caused by a reaction to drugs causes wide spread skin destruction)
Blood urine present

What are the common drug interactions of Entecavir and Coenzyme Q10, by age (0-1 to 60+)? *:

0-1:

n/a

2-9:

n/a

10-19:

n/a

20-29:

n/a

30-39:

Toxic epidermal necrolysis (a rare, life-threatening skin condition that is usually caused by a reaction to drugs causes wide spread skin destruction)

40-49:

n/a

50-59:

Crying
Depression
Insomnia (sleeplessness)
Stress

60+:

Biliary tract infection
Pneumonia
White blood cell count decreased
Presyncope
Cytokine release syndrome (immediate complication occurring with the use of anti-t cell antibody infusions)
Alanine aminotransferase increased
Aspartate aminotransferase increased
Bone marrow failure
Oxygen saturation decreased
Pneumonitis (inflammation of the walls of the alveoli in the lungs)

What are the existing conditions these people have? *

Non-Hodgkin's Lymphoma (malignant (cancer) cells form in the lymph system): 5 people, 31.25%
Urination - Excessive Volume: 2 people, 12.50%
Local Anaesthesia: 2 people, 12.50%
Agranulocytosis (a deficiency of granulocytes in the blood, causing increased vulnerability to infection): 2 people, 12.50%
Diarrhea: 2 people, 12.50%
Essential Hypertension (primary hypertension): 2 people, 12.50%
Gastroesophageal Reflux Disease (a condition in which stomach contents leak backward from the stomach into the oesophagus): 2 people, 12.50%
Hypokalemia (low potassium): 2 people, 12.50%
Urinary Incontinence (inability to control the flow of urine and involuntary urination): 2 people, 12.50%
Abdominal Pain: 2 people, 12.50%

* Approximation only. Some reports may have incomplete information.

Do you take Entecavir and Coenzyme q10?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously